SCHEMBL12469546

SCHEMBL12469546

O=[N+]([O-])c1cc(C2CCC(c3ccc(Cl)c([N+](=O)[O-])c3)N2c2ccc(OCC3COCO3)cc2)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.36
ALDH1A1 P00352 4/20 0.34
LMNA P02545 3/20 0.34
PKM P14618 2/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 3/20 0.33
NPC1 O15118 2/20 0.33
MITF O75030 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
VCAM1 P19320 1/20 0.33
MEN1 O00255 3/20 0.33
ESR1 P03372 1/20 0.33
SLC5A1 P13866 1/20 0.32
SLC5A2 P31639 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239565 1.00 KMT2A (0.36) KMT2AALDH1A1LMNAPKMGAA
SCHEMBL240708 0.82 SMN1; SMN2 (0.34) KMT2AALDH1A1LMNAPKMGAA
SCHEMBL241050 0.81 MAPT (0.42) KMT2AALDH1A1LMNAGAAMAPT
SCHEMBL239694 0.79 MAPT (0.36) KMT2AALDH1A1LMNAGAAMAPT
SCHEMBL240689 0.79 ALDH1A1 (0.36) KMT2AALDH1A1LMNAPKMGAA
SCHEMBL239658 0.78 KMT2A (0.43) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL12469738 0.78 KMT2A (0.43) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL240878 0.76 KAT2B (0.42) KMT2AALDH1A1LMNAPKMGAA
SCHEMBL240751 0.76 SMN1; SMN2 (0.42) KMT2AALDH1A1LMNAPKMGAA
SCHEMBL238882 0.75 KAT2B (0.41) KMT2AALDH1A1LMNAPKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678334-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2014-01-01 EP disclosed
EP-2627651-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-08-21 EP disclosed
WO-2012116257-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. (US) 2012-08-30 WO disclosed
WO-2012051361-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-04-19 WO disclosed